, Volume 68, Issue 6, pp 2677–2686 | Cite as

Multiplacenta derived stem cell/cytokine treatment increases survival time in a mouse model with radiation-induced bone marrow damage

  • Jun Li
  • Yunfang Wei
  • Lei Yan
  • Rui Wang
  • Ying Zhang
  • Yingzhen Su
  • Zhaoyu Yang
  • Min Hu
  • Rui Qi
  • Hongbo Tan
  • Qiong Wu
  • Xudong Yin
  • Xinghua PanEmail author
Original Article


Nuclear Warfare and nuclear leakage can result in a large number of patients with radiation-induced bone marrow damage. Based on the fact that hematopoietic stem cells and hematopoietic growth factors are characterized as a novel strategy for therapy, the aim of this study was to explore a safe and routine stem cell/cytokine therapeutic strategy. Allogeneic multiplacenta derived hematopoietic and mesenchymal stem cells/cytokines were intraperitoneally injected into a moderate dose of total body irradiation-induced mouse bone marrow damage model a single time. Then, the mouse posttransplantation survival time, peripheral blood hemoglobin count, bone marrow architecture, and donor cell engraftment were assessed. Each mouse that received placenta-derived stem cells exhibited positive donor hematopoietic and mesenchymal stem cell engraftment both in the bone marrow and peripheral blood after transplantation. The peripheral blood hemoglobin count and survival time were greater in the group with the combined treatment of multiplacenta-derived stem cells and cytokines, compared with model-only controls (both P < 0.001). The blood smear mesenchymal/hematopoietic stem cell count was significantly higher in the combined treatment group than in the mice treated only with placenta-derived cells (28.08 ± 5.824 vs. 20.40 ± 5.989, P < 0.001; 7.74 ± 2.153 vs. 4.23 ± 1.608, P < 0.001, respectively). However, there was no marked change on the bone marrow pathology of any of the experimental mice after the transplantation. These results indicate that for radiation-induced bone marrow damage treatment, multiplacenta-derived stem cells and cytokines can increase the life span of model mice and delay but not abrogate the disease progression. Intraperitoneally transplanted stem cells can survive and engraft into the host body through the blood circulation. Improvement of peripheral blood hemoglobin levels, but not the bone marrow architecture response, probably explains the increase in survival time observed in this study.


Placenta Stem cell Cytokine Radiation-induced bone marrow damage 



This work was supported by grants from the National Science and Technology Supporting Plan (2014B101B01-5), National Key Basic Research Project (2012CB58100-6), Applied Basic Research Project of Yunnan Provincial Science and Technology Department (2011FZ322, 2011FB087, 2013FZ097), and 2012 year Undergraduate Student Innovation & Carve Out training program granting project of Yunnan Province. We thank the staff of the State Local Joint Engineering Laboratory of Stem Cell and Immunocyte Biomedical Technology, Kunming General Hospital of Chengdu Military Command for their valuable technical assistance.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. Audet J, Miller CL, Eaves CJ, Piret JM (2002) Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng 80:393–404CrossRefGoogle Scholar
  2. Augustine AD, Gondre-Lewis T, McBride W, Miller L, Pellmar TC, Rockwell S (2005) Animal models for radiation injury, protection and therapy. Radiat Res 164:100–109CrossRefGoogle Scholar
  3. Banerjee KK, Bishayee A, Chatterjee M (1992) Anti-inflammatory effect of human placental extract: a biochemical mechanistic approach. Riv Eur Sci Med Farmacol 14:361–366Google Scholar
  4. Blazar BR, Taylor PA, Vallera DA (1995) In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T and B-cell functional capabilities. Blood 11:4353–4366Google Scholar
  5. Chaudhary LR, Spelsberg TC, Riggs BL (1992) Production of various cytokines by normal human osteoblast-like cells in response to IL1 and tumor necrosis factora. Endocrinology 130:2528–2534Google Scholar
  6. Coleman CN, Blakely WF, Fike JR, MacVittie TJ, Metting NF, Mitchell JB, Moulder JE, Preston RJ, Seed TM, Wong RS (2003) Molecular and cellular biology of moderate-dose (1–10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland. December 17–18, 2001. Radiat Res 6:812–834CrossRefGoogle Scholar
  7. Coleman CN, Stone HB, Moulder JE, Pellmar TC (2004) Modulation of radiation injury. Science 304:693–694CrossRefGoogle Scholar
  8. David McKenna D, Sheth J J (2011) Umbilical cord blood: current status and promise for the future. Indian J Med Res 3:261–269Google Scholar
  9. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I (2006) The role of mesenchymal stem cells in haemopoiesis. Blood Rev 20:161–171CrossRefGoogle Scholar
  10. Farese AM, Herodin F, McKearn JP, Baum C, Burton E, MacVittie TJ (1996) Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood 87:581–591Google Scholar
  11. Ghionzoli M, Cananzi M, Zani A, Rossi CA, Leon FF, Pierro A, Eaton S (2010) Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int 1:79–84CrossRefGoogle Scholar
  12. Grebnev DY, Maklakova IY, Yastrebov AP (2015) The prospect of using stem cells to activate hematopoiesis during age-related involution under radiation exposure. Adv Gerontol 2:80–83CrossRefGoogle Scholar
  13. Greenberger JS, Anderson J, Berry LA, Epperly M, Cronkite EP, Boggs SS (1996) Effects of irradiation of CBA/CA mice on hematopoietic stem cells and stromal cells in longterm bone marrow cultures. Leukemia 10:514–527Google Scholar
  14. Hérodin F, Drouet M (2005) Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 33:1071–1080CrossRefGoogle Scholar
  15. Hérodin F, Bourin P, Mayol JF, Lataillade JJ, Drouet M (2003) Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma-irradiation promotes survival. Blood 101:2609–2616CrossRefGoogle Scholar
  16. Hérodin F, Mayol JF, Mourcin F, Drouet M (2005) Which place for stem cell therapy in the treatment of acute radiation syndrome? Folia Histochem Cytobiol 43:223–227Google Scholar
  17. Hirama T, Tanosaki S, Kandatsu S, Kuroiwa N, Kamada T, Tsuji H, Yamada S, Katoh H, Yamamoto N, Tsujii H, Suzuki G, Akashi M (2003) Initial medical management of patients severely irradiated in the Tokai-mura criticality accident. Br J Radiol 76:246–253CrossRefGoogle Scholar
  18. Hu KX, Sun QY, Guo M, AI HS (2010) The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br J Radiol 83:52–58CrossRefGoogle Scholar
  19. Kadekar D, Kale V, Limaye L (2015) Differential ability of MSCs isolated fromplacenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34+ cells. Stem Cell Res Ther 1:1–20Google Scholar
  20. Koenig KL, Goans RE, Hatchett RJ, Mettler FA Jr, Schumacher TA, Noji EK, Jarrett DG (2005) Medical treatment of radiological casualties: current concepts. Ann Emerg Med 45:643–652CrossRefGoogle Scholar
  21. Lazzari L, Lucchi S, Rebulla P, Porretti L, Puglisi G, Lecchi L, Sirchia G (2001) Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin Flt3-ligand interleukin IL-6 and IL-11 in aserum-free and stroma-free culture system. Br J Haematol 112:397–404CrossRefGoogle Scholar
  22. Li J, Zhang L, Zhou L, Yu ZP, Qi F, Liu B, Zi SX, Li L, Li Y, Wang SB, Cui ZJ, Pan XH (2012) Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis. J Transl Med 10:102CrossRefGoogle Scholar
  23. Li J, Chen H, Lv YB, Wang Q, Xie ZJ, Ma LH, He J, Xue W, Yu S, Guo J, Wang TH, Wu TX, Pan XH (2016) Intraperitoneal injection of multiplacentas pooled cells treatment on a mouse model with aplastic anemia. Stem Cells Int. doi: 10.1155/2016/3279793 Google Scholar
  24. MacVittie TJ (1997) Therapy of radiation injury. Stem Cells 15:263–268CrossRefGoogle Scholar
  25. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL (1998) Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells and stromal cells. J Cell Physiol 176:186–192CrossRefGoogle Scholar
  26. McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ (2004) Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 4:311–317CrossRefGoogle Scholar
  27. Meng A, Wang Y, Van ZG, Zhou D (2003) Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res 63:5414–5419Google Scholar
  28. Mettler FA Jr, Voelz GL (2002) Major radiation exposure-what to expect and how to respond. N Engl J Med 346:1554–1561CrossRefGoogle Scholar
  29. Noll T, Jelinek N, Schmidt S, Biselli M, Wandrey C (2002) Cultivation of hematopoietic stem cells: biochemical engineering aspects. Adv Biochem Eng Biotechnol 74:111–128Google Scholar
  30. Park SY, Phark S, Lee M, Lim JY, Sul D (2010) Anti-oxidative and anti-inflammatory activities of placental extracts in benzo[a] pyrene-exposed rats. Placenta 31:873–879CrossRefGoogle Scholar
  31. Pellmar TC, Rockwell S (2005) Priority list of research areas for radiological nuclear threat counter measures. Radiat Res 163:115–123CrossRefGoogle Scholar
  32. Piscaglia AC, Di Campli C, Zocco MA, Di Gioacchino G, Novi M, Rutella S, Bonanno G, Monego G, Vecchio FM, Michetti F, Mancuso S, Leone G, Gasbarrini G, Pola P, Gasbarrini A (2005) Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. Transpl Proc 6:2711–2714CrossRefGoogle Scholar
  33. Quelle FW, Wang JL, Feng J, Wang D, Cleveland JL, Ihle JN, Zambetti GP (1998) Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev 12:1099–1107CrossRefGoogle Scholar
  34. Shao L, Feng W, Li H, Gardner D, Luo Y, Wang Y, Liu L, Meng A, Sharpless NE, Zhou D (2014) Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner. Blood 20:3105–3115CrossRefGoogle Scholar
  35. Smogorzewska EM, Barsky LW, Crooks GM, Wienberg KI (1997) Purification of hematopoietic stem cells from human bone marrow and umbilical cord blood. Cent Eur J Immunol 22:232–239Google Scholar
  36. Sorrentino A, Ferracin Mcastelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 8:1035–1046CrossRefGoogle Scholar
  37. Sur TK, Biswas TK, Ali L, Mukherjee B (2003) Anti-inflammatory and anti-platelet aggregation activity of human placental extract. Acta Pharmacol Sin 2:187–192Google Scholar
  38. Togashi S, Takahashi N, Kubo Y, Shigihara A, Higashiyama K, Watanabe S, Fukui T (2000) Purification and identification of antioxidant substances in human-placenta extracts. J Health Sci 6:17–25Google Scholar
  39. Tolar J, Le Blanc K, Keating A, Blazar B (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 8:1446–1455CrossRefGoogle Scholar
  40. Van derMeeren A, Mouthon MA, Gaugler MH, Vandamme M, Gourmelon P (2002) Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin. Radiat Res 157:642–649CrossRefGoogle Scholar
  41. Vávrová J, Vokurková D, Mareková M, Bláha M, Jebavý L, Filip S (2002) Antiapoptotic cytokine IL-3 + SCF + FLT3L influence on proliferation of gamma-irradiated AC133 +/CD34 + progenitor cells. Folia Biol 48:51–57Google Scholar
  42. Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D (2006) Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 107:358–366CrossRefGoogle Scholar
  43. Waselenko JK, MacVittie TJ, Blakely WF, Pesik NT, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N (2004) Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140:1037–1051CrossRefGoogle Scholar
  44. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA (2006) Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 11:2582–2591CrossRefGoogle Scholar
  45. Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA (2011) Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112:1206–1218CrossRefGoogle Scholar
  46. Zhou G, Chen J, Lee S, Clark T, Rowley JD, Wang SM (2001) The pattern of gene expression in human CD34+ stem/progenitor cells. Proc Natl Acad Sci USA 98:13966–13971CrossRefGoogle Scholar
  47. Zhu Y, Yang Y, Zhang Y, Hao G, Liu T, Wang L, Yang T, Wang Q, Zhang G, Wei J, Li Y (2014) Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther 2:48CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Jun Li
    • 1
    • 2
  • Yunfang Wei
    • 1
  • Lei Yan
    • 3
  • Rui Wang
    • 1
  • Ying Zhang
    • 1
  • Yingzhen Su
    • 1
  • Zhaoyu Yang
    • 1
  • Min Hu
    • 4
  • Rui Qi
    • 1
  • Hongbo Tan
    • 5
  • Qiong Wu
    • 6
  • Xudong Yin
    • 7
  • Xinghua Pan
    • 2
    Email author
  1. 1.Medical School of Kunming UniversityKunmingChina
  2. 2.State Local Joint Engineering Laboratory of Stem Cell and Immunocyte Biomedical TechnologyKunming General Hospital of Chengdu Military CommandKunmingChina
  3. 3.Anesthesiology DepartmentPeople’s Hospital of Xinjiang Uygur Autonomous RegionUrumqiChina
  4. 4.Research Center for Molecular MedicineKunming UniversityKunmingChina
  5. 5.Orthopedics DepartmentKunming General Hospital of Chengdu Military CommandKunmingChina
  6. 6.Department of Chemical Science and TechnologyKunming UniversityKunmingChina
  7. 7.Department of Life Science and TechnologyKunming UniversityKunmingChina

Personalised recommendations